Electric pulses and chemo aim to stop pancreatic cancer return

NCT ID NCT04281290

Ongoing Disease control Sponsor: University Medical Centre Ljubljana Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests whether applying electrochemotherapy (electric pulses plus the drug bleomycin) to the area where a pancreatic tumor was removed can lower the chance of cancer coming back. Ten patients with resectable pancreatic cancer will receive the treatment during surgery. The main goal is to check safety and see if it reduces local recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bleomycin
What this could lead to: If it works, this could point toward a way to reduce local recurrence after pancreatic cancer surgery.
What could go wrong: This is a very early, small trial (10 patients) testing safety and feasibility. It may not show a clear benefit, and there are risks from surgery and the electrochemotherapy procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREAS CANCER

Contacts and locations

Locations

University Medical Centre Ljubljana, Ljubljana, Slovenia

Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.